Literature DB >> 20368199

Apo-B/AI ratio identifies cardiovascular risk in childhood: the Australian Aboriginal Birth Cohort study.

Elizabeth A C Sellers1, Gurmeet R Singh, Susan M Sayers.   

Abstract

We describe the lipoprotein and apolipoprotein profiles and their relationship to cardiovascular risk factors in Australian Aboriginal children. This cross-sectional study within a longitudinal birth cohort study involved Australian Aboriginal children born between 1987 and 1990 and re-examined between 1998 and 2001. Height, weight, blood pressure, waist circumference, body fat percentage, cholesterol, triglycerides, HDL-c, LDL-c, apolipoprotein B and A1 were measured. Mean age was 11.4 years (52% male). Mean cholesterol, triglyceride, HDL-c and LDL-c did not differ from reference data. Measures of obesity, blood pressure and prevalence of the metabolic syndrome did not differ in those children with lipoproteins in the upper quartile of the cohort (lower quartile for HDL-c). Boys with an Apo-B/A1 ratio in the upper quartile of the cohort had higher BMI z-score, waist z-score, % body fat, diastolic blood pressure and frequency of the metabolic syndrome (p<0.05). In girls, waist circumference, % body fat and the prevalence of the metabolic syndrome was higher in those with an Apo-B/A1 ratio in the upper quartile (p<0.05).The Apo-B/A1 ratio may be useful to identify cardiovascular risk in Australian Aboriginal children and is suited to clinical practice as the assays are standardised, accurate, automated and a fasting sample is not required.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20368199     DOI: 10.1177/1479164109336046

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  3 in total

1.  Apo B/Apo A-I Ratio is Statistically A Better Predictor of Cardiovascular Disease (CVD) than Conventional Lipid Profile: A Study from Kathmandu Valley, Nepal.

Authors:  Hem Kumar Tamang; Uddhav Timilsina; Khelanand Prasad Singh; Sanjit Shrestha; Ramendra Kumar Raman; Pujan Panta; Preeti Karna; Laxmi Khadka; Chandika Dahal
Journal:  J Clin Diagn Res       Date:  2014-02-03

Review 2.  Treatment of dyslipidemia in patients with type 2 diabetes.

Authors:  Krishnaswami Vijayaraghavan
Journal:  Lipids Health Dis       Date:  2010-12-20       Impact factor: 3.876

Review 3.  Dyslipidemia in Pediatric Type 2 Diabetes Mellitus.

Authors:  Bhuvana Sunil; Ambika P Ashraf
Journal:  Curr Diab Rep       Date:  2020-09-09       Impact factor: 4.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.